Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis who have had an Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from a Network Meta-Analysis
Clin Ther 2016;38:2628–40.
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Clin Ther 2016;38:2628–40.
Cochrane Database Syst Rev 2016;11:CD012437.
Arthritis Rheumatol 2016. DOI:10.1002/art.39944.
Ann Rheum Dis 2016. DOI 10.1136/annrheumdis-2016-210310
Arthritis Res Ther 2016; 18:211. DOI 10.1186/s13075-016-1108-9
Arthritis Care Res 2016; Accepted article. DOI 10.1002/acr.23004
Arthritis Rheumatol 2016; Accepted article DOI 10.1002/art-39808 [Epub 2016]
Ann Rheum Dis 2016;0:1–7 DOI 10.1136/annrheumdis-2016-209773.
Cochrane Database of Systematic Reviews 2016 Issue 5. Art. No.: CD012183 [DOI: 10.1002/14651858.CD012183].
Arthritis Rheumatol. 2016 May 17. DOI 10.1002/art.39761 [Epub ahead of print]